MacroGenics Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, MacroGenics stock has a consensus rating of "Buy" and an average price target of $6.75. The average 1-year stock price forecast is 74.19% higher than the current stock price, while the lowest is $4.00 (+3.23%) and the highest is $9.00 (+132.26%).

Price Target: $6.75 (+74.19%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$6.75	$7.00	$9.00
Change	+3.23%	+74.19%	+80.65%	+132.26%

Analyst Ratings

The average analyst rating for MacroGenics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '25	Nov '25	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	1	1	1	1	2	2
Buy	1	1	1	1	1	1
Hold	4	5	5	5	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mayank Mamtani B. Riley Securities	B. Riley Securities	Buy Maintains $9	Buy	Maintains	$9	+132.26%	May 22, 2026
Stephen Willey Stifel Nicolaus	Stifel Nicolaus	Hold Maintains $4	Hold	Maintains	$4	+3.23%	May 14, 2026
Etzer Darout Barclays	Barclays	Buy Reiterates $6	Buy	Reiterates	$6	+54.84%	May 14, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	May 7, 2026
Tara Bancroft TD Cowen	TD Cowen	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

164.39M

from 149.50M

9.96%

from 149.50M

Revenue Next Year

94.26M

from 164.39M

-42.66%

from 164.39M

EPS This Year

0.04

from -1.18

EPS Next Year

-1.41

from 0.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	77.45M	151.94M	58.75M	149.96M	149.50M	164.39M
Revenue Growth	-26.16%	96.19%	-61.33%	155.26%	-0.31%	9.96%
Gross Profit	-139.78M	-62.47M	-116.06M	-39.53M	-33.68M	164.39M
Gross Margin	-180.49%	-41.11%	-197.55%	-26.36%	-22.53%	100.00%
Operating Income	-202.80M	-121.42M	-168.24M	-110.58M	-72.84M	-85.03M
Net Income	-202.12M	-119.76M	-9.06M	-66.97M	-74.62M	-18.31M
EPS	-	-	-	-	-1.18	0.04
Forward PE	-	-	-	-	-	110.71
Free Cash Flow	-71.23M	-105.11M	-25.04M	-32.49M	-58.23M	24.73M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	218.0M
Avg	164.4M
Low	132.8M

Revenue Growth

Revenue Growth	2026	2027	2028
High	45.8%
Avg	10.0%
Low	-11.2%

EPS Forecast

EPS	2026	2027	2028
High	0.81
Avg	0.04
Low	-0.74

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-